November 26, 2020: SkyCell and Air France KLM Martinair Cargo have signed a partnership agreement which sets out the reintroduction of hybrid containers for those shipping with the carrier, supporting a push to increase the sustainability and safety of pharmaceutical shipments.

The agreement coincides with rising demand for greener solutions and ambitious environmental goals set out by pharma companies. As the pharma logistics industry pushes to prepare for a future global distribution of Covid-19 vaccines, sustainable solutions will be crucial given the volume and global scale of the distribution ahead. Since SkyCell's solutions are able to secure products within a temperature range of 2 - 8°C and 15 - 25°C and now -70°C, SkyCell is well-prepared for the varying needs of vaccines and other sensitive pharmaceuticals.

The deal with Air France KLM Martinair Cargo is part of a shift towards the adoption of enhanced technological solutions to meet both the demands of pandemic logistics and requirements of environmental agreements.

Enrica Calonghi, global head pharmaceutical logistics at Air France KLM Martinair Cargo, stated, “Shipping pharma and healthcare products is a core activity for AFKLMP Cargo. Partnerships, such as those with our container suppliers, play a crucial role in the entire chain, especially when it comes to guaranteeing the necessary quality, reliability and connectivity. Together, we are ready to play a key role in the distribution of Covid-19 vaccines, thereby helping to ensure that as many people as possible around the globe will have access to vaccines in these challenging times.”

Richard Ettl, CEO, SkyCell, commented, “Air France KLM Martinair Cargo is a pioneer in pharmaceutical air freight and, like SkyCell, is committed to minimising its environmental footprint through technological innovation.”

Across SkyCell’s client base, SkyCell’s containers provide protection for about 202 hours (8.4 days) on average, which is extended by trucking or storage under refrigerated conditions.